Maria Clelia Gervasi

University of Verona

Papers

1

Total Citations

17

H-Index

1

About

Dr. Maria Clelia Gervasi is a leading figure in thoracic surgical oncology, with a focused expertise in minimally invasive and robotic-assisted esophagectomy. Her research centers on optimizing surgical techniques for esophageal cancer, particularly through comparative analyses of robotic versus open approaches. Her most cited work, a 2023 study on robotic versus open Ivor-Lewis esophagectomy, demonstrates that robotic-assisted minimally invasive esophagectomy (RAMIE) achieves a more accurate lymph node dissection without increasing the burden of anastomotic leaks—a critical balance in oncologic surgery. This contribution has garnered 17 citations, reflecting its immediate impact on surgical practice. Dr. Gervasi’s work is notable for advancing the evidence base that robotic techniques can enhance oncologic precision while maintaining safety profiles comparable to open surgery. Her research addresses a key challenge in esophagectomy: improving lymph node yield without compromising postoperative outcomes. For students and researchers, Dr. Gervasi exemplifies how rigorous comparative studies can refine surgical standards, offering a pathway to better patient outcomes through technological innovation.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus open Ivor–Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate
17 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of Verona

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago